- Report
- October 2024
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 190 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
Global
From €2329EUR$2,450USD£1,957GBP
- Report
- March 2025
- 289 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 282 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 387 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 149 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 134 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 235 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 183 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 94 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP

The Neuroprotective market is a subset of Central Nervous System (CNS) drugs that are designed to protect the brain and spinal cord from damage caused by disease, trauma, or other conditions. Neuroprotective drugs are used to treat a variety of neurological disorders, including stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. These drugs can also be used to reduce the risk of developing these conditions. Neuroprotective drugs work by reducing inflammation, improving blood flow, and protecting neurons from damage.
Neuroprotective drugs are an important part of treating neurological disorders, as they can help reduce the severity of symptoms and improve quality of life. They are also used to prevent further damage to the brain and spinal cord.
Some companies in the Neuroprotective market include AbbVie, AstraZeneca, Biogen, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more